These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30455534)

  • 41. Donors, Noncommunicable Diseases, and Universal Health Coverage to High-quality Healthcare: An Opportunity for Action on Global Functions for Health.
    Baines LS; Kerr DJ
    J Epidemiol Glob Health; 2018 Dec; 8(3-4):236. PubMed ID: 30864770
    [No Abstract]   [Full Text] [Related]  

  • 42. Point-of-Care Diagnostics in Low-Resource Settings and Their Impact on Care in the Age of the Noncommunicable and Chronic Disease Epidemic.
    Weigl BH; Neogi T; McGuire H
    J Lab Autom; 2014 Jun; 19(3):248-57. PubMed ID: 24366968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acting on NCDs: counting the cost.
    Ghebreyesus TA
    Lancet; 2018 May; 391(10134):1973-1974. PubMed ID: 29627165
    [No Abstract]   [Full Text] [Related]  

  • 44. WHO global meeting to accelerate progress on SDG target 3.4 on noncommunicable diseases and mental health.
    East Mediterr Health J; 2021 May; 27(5):524-525. PubMed ID: 34080682
    [No Abstract]   [Full Text] [Related]  

  • 45. Mongolia's Public Spending On Noncommunicable Diseases Is Similar To The Spending Of Higher-Income Countries.
    Dugee O; Munaa E; Sakhiya A; Mahal A
    Health Aff (Millwood); 2017 May; 36(5):918-925. PubMed ID: 28461360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urbanisation, inequality, and non-communicable disease risk.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2017 May; 5(5):313. PubMed ID: 28395876
    [No Abstract]   [Full Text] [Related]  

  • 47. A Platform to Accelerate Global Reductions in Chronic Diseases: Toward Action.
    Ruchman SG; Kishore SP; Singh P
    Glob Heart; 2016 Dec; 11(4):421-423. PubMed ID: 27938830
    [No Abstract]   [Full Text] [Related]  

  • 48. The causal impact of ART on NCDs: leveraging quasi-experiments.
    Manne-Goehler J; Geldsetzer P; Bärnighausen T
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):14. PubMed ID: 28010784
    [No Abstract]   [Full Text] [Related]  

  • 49. Which Threats to Global Health Pose a Problem for Turkey’s Health?
    Tokuç B
    Balkan Med J; 2019 May; 36(3):152-154. PubMed ID: 30821137
    [No Abstract]   [Full Text] [Related]  

  • 50. Noncommunicable Disease Risk Factors in Developing Countries: Policy Perspectives.
    Kostova D; Chaloupka FJ; Frieden TR; Henning K; Paul J; Osewe PL; Asma S
    Prev Med; 2017 Dec; 105S():S1-S3. PubMed ID: 28988998
    [No Abstract]   [Full Text] [Related]  

  • 51. The Triple Challenges of Low and Middle-Income Countries.
    Haileamlak A
    Ethiop J Health Sci; 2018 Jan; 28(1):1-2. PubMed ID: 29622901
    [No Abstract]   [Full Text] [Related]  

  • 52. The how: a message for the UN high-level meeting on NCDs.
    Friends of the UN HLM on NCDs
    Lancet; 2018 Jul; 392(10143):e4-e5. PubMed ID: 29961641
    [No Abstract]   [Full Text] [Related]  

  • 53. Recognizing the roles of primary health care in addressing non-communicable diseases in low- and middle-income countries: Lesson from COVID-19, implications for the future.
    Yadav UN; Mistry SK; Ghimire S; Schneider CH; Rawal LB; Acharya SP; Harris-Roxas B; Harris MF
    J Glob Health; 2021; 11():03120. PubMed ID: 34804511
    [No Abstract]   [Full Text] [Related]  

  • 54. Developmental Origins of Health and Disease: the relevance to developing nations.
    Mandy M; Nyirenda M
    Int Health; 2018 Mar; 10(2):66-70. PubMed ID: 29528398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes and NCD research: meeting the needs of the patient.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):873. PubMed ID: 27793312
    [No Abstract]   [Full Text] [Related]  

  • 56. The future of the global noncommunicable disease agenda after Covid-19.
    Herrick C; Reubi D
    Health Place; 2021 Sep; 71():102672. PubMed ID: 34543839
    [No Abstract]   [Full Text] [Related]  

  • 57. Contribution of the North Karelia Project to International Work in CVD and NCD Prevention and Health Promotion.
    Puska P; Laatikainen T; Korpelainen V; Vartiainen E
    Glob Heart; 2016 Jun; 11(2):243-6. PubMed ID: 27242094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multimorbidity: Not Just for the West.
    Banerjee A; Hurst J; Fottrell E; Miranda JJ
    Glob Heart; 2020 Jul; 15(1):45. PubMed ID: 32923339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The commercial determinants of health.
    Kickbusch I; Allen L; Franz C
    Lancet Glob Health; 2016 Dec; 4(12):e895-e896. PubMed ID: 27855860
    [No Abstract]   [Full Text] [Related]  

  • 60. Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple?
    Balbi B; Marcassa C; Pisani F; Corica G; Spanevello A
    Monaldi Arch Chest Dis; 2017 May; 87(1):818. PubMed ID: 28635206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.